SEPİCİ DİNÇEL, A. Et Al. 2017. ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases , (Florence, Italy).

SEPİCİ DİNÇEL, A., Ayturk, S. A., Taskiran, O. O., Demirsoy, N., & Sepici, V., (2017). ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS . WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Florence, Italy

SEPİCİ DİNÇEL, AYLİN Et Al. "ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS," WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Florence, Italy, 2017

SEPİCİ DİNÇEL, AYLİN S. Et Al. "ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS." WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases , Florence, Italy, 2017

SEPİCİ DİNÇEL, A. Et Al. (2017) . "ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS." WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases , Florence, Italy.

@conferencepaper{conferencepaper, author={AYLİN SEPİCİ DİNÇEL Et Al. }, title={ROLE OF PHARMACOGENOMICS IN EFFECTIVENESS OF BISPHOSPHONATES IN TREATMENT OF OSTEOPOROTIC PATIENTS}, congress name={WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases}, city={Florence}, country={Italy}, year={2017}}